Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations
about
Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposuresRedefining ALL classification: toward detecting high-risk ALL and implementing precision medicineCurrent concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemiaGenetic and nongenetic risk factors for childhood cancerChildhood acute lymphoblastic leukemia: Integrating genomics into therapyChildhood Acute Lymphoblastic Leukemia: Progress Through CollaborationGenomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia.Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse.Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemiaGenomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemiaRegulatory network of GATA3 in pediatric acute lymphoblastic leukemiaARID5B gene rs10821936 polymorphism is associated with childhood acute lymphoblastic leukemia: a meta-analysis based on 39,116 subjects.Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.ARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: the ESCALE study.Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study.Association Between PIP4K2A Polymorphisms and Acute Lymphoblastic Leukemia Susceptibility.Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose.Biology of childhood acute lymphoblastic leukemia.The National Longitudinal Study of Adolescent to Adult Health (Add Health) sibling pairs genome-wide data.A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults.ARID5B polymorphism confers an increased risk to acquire specific MLL rearrangements in early childhood leukemia.Perinatal and familial risk factors for acute lymphoblastic leukemia in a Swedish national cohort.Contribution of polymorphisms in IKZF1 gene to childhood acute leukemia: a meta-analysis of 33 case-control studies.Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.Association between CEBPE Variant and Childhood Acute Leukemia Risk: Evidence from a Meta-Analysis of 22 Studies.Genome-Wide Association Studies of HIV-1 Host Control in Ethnically Diverse Chinese PopulationsInherited genetic variation in childhood acute lymphoblastic leukemia.Somatic Mutation Allelic Ratio Test Using ddPCR (SMART-ddPCR): An Accurate Method for Assessment of Preferential Allelic Imbalance in Tumor DNA.Race/ethnicity and the risk of childhood leukaemia: a case-control study in CaliforniaChildhood cancer: an emerging public health issue in China.A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution.A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology.Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1.A functional polymorphism in the CEBPE gene promoter influences acute lymphoblastic leukemia risk through interaction with the hematopoietic transcription factor Ikaros.Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcomaAnalysis of possible genetic risk factors contributing to development of childhood acute lymphoblastic leukaemia in the Latvian population.A 50-year journey to cure childhood acute lymphoblastic leukemiaGenetic loss of SH2B3 in acute lymphoblastic leukemia.Gene and Network Analysis of Common Variants Reveals Novel Associations in Multiple Complex Diseases.
P2860
Q21131918-16E27E53-01AC-4468-9C23-25CD2F30601DQ26864460-2F49D4C7-CCFE-4AA4-B2FB-770C9D7EF1D2Q27025242-D247928A-FBF4-4FB6-A04A-7C9FF9092138Q27693894-87B63234-1CC9-4E25-853E-24C4AE697682Q28080463-F071C870-B01D-4B08-BEB8-D39666B4F9EAQ28087637-66526168-6609-40B7-80C6-02CEB22DE587Q33586588-B17C634D-D7B2-4DB7-A8C7-CF6629E9A7B7Q33688248-A358A547-802F-4CE1-B770-67FDFE3C47DCQ33774499-9B90F457-E31A-4E07-B1B6-AD1F0B6C49BCQ33801063-1C0E56F9-8F06-4451-9C3E-2B00D2B84389Q33829399-7744060E-854A-4281-B514-D2EA9093F0A4Q34366595-A40069A6-D5B3-4936-98B5-C571FA03B12BQ34466695-FE990B00-319C-4F5A-B2C5-5A27B5159B00Q34468538-4AF465E6-A695-46A7-8302-DE6EF0B8FC03Q34482019-058B600C-ED9D-4D33-87D5-6E45D3DE6F4FQ34500075-6B61676E-56E9-45F0-8F6E-D089DC58CC82Q34525231-7DD88004-48C5-4C1A-82F0-FC25DCD8A915Q34549324-F7145B1A-DC06-4139-8F1C-997FA2768913Q34605953-632FED85-E193-4EEF-BE0C-D2517000FBC6Q34902205-71B53E7A-1938-4B37-ABB2-3FBF3782827DQ35004970-9B4D5490-203D-48A6-BD5C-2FAD47F53510Q35101250-D8421353-256F-48FB-9C90-E6F026297851Q35202354-A17376CE-C036-4669-A965-FDEFBDEA11ADQ35448434-B4AA2A6E-58DF-486E-8BCD-500CB0DA9915Q35565624-8198DC1B-0C04-4900-A40C-07C6D7ED718BQ35621513-8684373F-DA30-4423-90AD-53FEF00E8FDDQ35679190-A637AAB6-69E6-4916-BB5C-A289F6AB45EEQ35784497-619E3260-3464-4825-8BD6-E69D5A6224D4Q35843497-7B8B93B3-0BD7-4160-8E66-E632E3754C59Q35998086-9EAA1F0B-5A9F-48F3-A008-FC9863D3C065Q36204952-936AB2B9-3E8C-420F-B667-69140E894B99Q36296543-3C36ACC6-D258-4E30-9631-EAB54618E56AQ36582277-EFE6988B-ECF3-4BBC-B9AE-E109FBB009E5Q36668971-011083FD-7029-4818-838D-89B7E516DFB6Q36693283-FCD86E17-2D09-497E-8A5E-48718AB409EEQ36717196-D401C1FE-C68C-4E49-8F9C-46565D6050EDQ36958247-78D2D492-7047-412D-AEAB-933C104B7AD0Q37166753-92673A20-1777-410A-AA20-45FC015463EFQ37215146-7294EF20-63D4-4279-A6F9-407491F9E598Q37347795-A4CAD60A-2D60-453B-A5F9-9E975096F424
P2860
Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations
description
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2013
@ast
im Mai 2013 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
wetenschappelijk artikel (gepubliceerd op 2013/05/15)
@nl
наукова стаття, опублікована в травні 2013
@uk
مقالة علمية (نشرت في 15-5-2013)
@ar
name
Novel susceptibility variants ...... ethnically diverse populations
@ast
Novel susceptibility variants ...... ethnically diverse populations
@en
type
label
Novel susceptibility variants ...... ethnically diverse populations
@ast
Novel susceptibility variants ...... ethnically diverse populations
@en
prefLabel
Novel susceptibility variants ...... ethnically diverse populations
@ast
Novel susceptibility variants ...... ethnically diverse populations
@en
P2093
P2860
P3181
P356
P1476
Novel susceptibility variants ...... ethnically diverse populations
@en
P2093
Bruce M. Camitta
Celeste Eng
Charles G. Mullighan
Cheng Cheng
Cheryl L. Willman
Dara G. Torgerson
Deepa Bhojwani
Deqing Pei
Esteban González Burchard
P2860
P304
P3181
P356
10.1093/JNCI/DJT042
P407
P577
2013-05-15T00:00:00Z